164 related articles for article (PubMed ID: 32873300)
1. Immune response of horses to inactivated African horse sickness vaccines.
Rodríguez M; Joseph S; Pfeffer M; Raghavan R; Wernery U
BMC Vet Res; 2020 Sep; 16(1):322. PubMed ID: 32873300
[TBL] [Abstract][Full Text] [Related]
2. Humoral antibody response of 10 horses after vaccination against African horse sickness with an inactivated vaccine containing all 9 serotypes in one injection.
Wernery U; Rodriguez M; Raghavan R; Syriac G; Miriam Thomas M S; Elizabeth SK; Federico Ronchi G; Muhammed R; Patteril NA; Joseph S
Equine Vet J; 2021 Jul; 53(4):826-833. PubMed ID: 33011979
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
[TBL] [Abstract][Full Text] [Related]
4. In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6.
von Teichman BF; Dungu B; Smit TK
Vaccine; 2010 Sep; 28(39):6505-17. PubMed ID: 20638456
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants.
van Rijn PA; Maris-Veldhuis MA; Grobler M; Wright IM; Erasmus BJ; Maartens LH; Potgieter CA
Vaccine; 2020 Oct; 38(45):7108-7117. PubMed ID: 32921506
[TBL] [Abstract][Full Text] [Related]
6. African Horse Sickness Fever in Vaccinated Horses: Short Communication.
Wernery U; Joseph S; Raghavan R; Dyer B; Spendrup S
J Equine Vet Sci; 2020 May; 88():102967. PubMed ID: 32303305
[TBL] [Abstract][Full Text] [Related]
7. [Use of the immunoenzyme test ELISA-NS3 to distinguish horses infected by African horsesickness virus from vaccinated horses].
Idrissi Bougrine S; Fassi Fihri O; el Harrak M; Fassi Fehri MM
Rev Sci Tech; 1999 Dec; 18(3):618-26. PubMed ID: 10588005
[TBL] [Abstract][Full Text] [Related]
8. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
[TBL] [Abstract][Full Text] [Related]
9. Serological response of foals to polyvalent and monovalent live-attenuated African horse sickness virus vaccines.
Crafford JE; Lourens CW; Smit TK; Gardner IA; MacLachlan NJ; Guthrie AJ
Vaccine; 2014 Jun; 32(29):3611-6. PubMed ID: 24814557
[TBL] [Abstract][Full Text] [Related]
10. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
van Rijn PA; Maris-Veldhuis MA; Potgieter CA; van Gennip RGP
Vaccine; 2018 Apr; 36(15):1925-1933. PubMed ID: 29525278
[TBL] [Abstract][Full Text] [Related]
11. Inactivated and adjuvanted vaccine for the control of the African horse sickness virus serotype 9 infection: evaluation of efficacy in horses and guinea-pig model.
Lelli R; Molini U; Ronchi GF; Rossi E; Franchi P; Ulisse S; Armillotta G; Capista S; Khaiseb S; Di Ventura M; Pini A
Vet Ital; 2013; 49(1):89-98. PubMed ID: 23564590
[TBL] [Abstract][Full Text] [Related]
12. Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses.
Durán-Ferrer M; Villalba R; Fernández-Pacheco P; Tena-Tomás C; Jiménez-Clavero MÁ; Bouzada JA; Ruano MJ; Fernández-Pinero J; Arias M; Castillo-Olivares J; Agüero M
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891525
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of African horse sickness virus nucleic acid and antibody in horses following immunization with a commercial polyvalent live attenuated vaccine.
Weyer CT; Grewar JD; Burger P; Joone C; Lourens C; MacLachlan NJ; Guthrie AJ
Vaccine; 2017 Apr; 35(18):2504-2510. PubMed ID: 28341113
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of two adjuvant formulations of an inactivated African horse sickness vaccine in guinea-pigs and target animals.
Ronchi GF; Ulisse S; Rossi E; Franchi P; Armillotta G; Capista S; Peccio A; Di Ventura M; Pini A
Vet Ital; 2012; 48(1):55-76. PubMed ID: 22485003
[TBL] [Abstract][Full Text] [Related]
15. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses.
Dennis SJ; O'Kennedy MM; Rutkowska D; Tsekoa T; Lourens CW; Hitzeroth II; Meyers AE; Rybicki EP
Vet Res; 2018 Oct; 49(1):105. PubMed ID: 30309390
[TBL] [Abstract][Full Text] [Related]
17. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.
Calvo-Pinilla E; Gubbins S; Mertens P; Ortego J; Castillo-Olivares J
Antiviral Res; 2018 Jun; 154():132-139. PubMed ID: 29678552
[TBL] [Abstract][Full Text] [Related]
18. Cross-protective immune responses against African horse sickness virus after vaccination with protein NS1 delivered by avian reovirus muNS microspheres and modified vaccinia virus Ankara.
Marín-López A; Barreiro-Piñeiro N; Utrilla-Trigo S; Barriales D; Benavente J; Nogales A; Martínez-Costas J; Ortego J; Calvo-Pinilla E
Vaccine; 2020 Jan; 38(4):882-889. PubMed ID: 31708178
[TBL] [Abstract][Full Text] [Related]
19. Antibodies in horses, mules and donkeys following monovalent vaccination against African horse sickness.
Hamblin C; Mellor PS; Graham SD; Hooghuis H; Montejano RC; Cubillo MA; Boned J
Epidemiol Infect; 1991 Apr; 106(2):365-71. PubMed ID: 1902185
[TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge.
Lulla V; Losada A; Lecollinet S; Kerviel A; Lilin T; Sailleau C; Beck C; Zientara S; Roy P
Vaccine; 2017 Jul; 35(33):4262-4269. PubMed ID: 28625521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
